...
首页> 外文期刊>Nucleic acids research >Integrative analysis of gene and miRNA expression profiles with transcription factor–miRNA feed-forward loops identifies regulators in human cancers
【24h】

Integrative analysis of gene and miRNA expression profiles with transcription factor–miRNA feed-forward loops identifies regulators in human cancers

机译:基因和miRNA表达谱与转录因子– miRNA前馈环的综合分析可确定人类癌症中的调节剂

获取原文

摘要

We describe here a novel method for integrating gene and miRNA expression profiles in cancer using feed-forward loops (FFLs) consisting of transcription factors (TFs), miRNAs and their common target genes. The dChip-GemiNI (Gene and miRNA Network-based Integration) method statistically ranks computationally predicted FFLs by their explanatory power to account for differential gene and miRNA expression between two biological conditions such as normal and cancer. GemiNI integrates not only gene and miRNA expression data but also computationally derived information about TF–target gene and miRNA–mRNA interactions. Literature validation shows that the integrated modeling of expression data and FFLs better identifies cancer-related TFs and miRNAs compared to existing approaches. We have utilized GemiNI for analyzing six data sets of solid cancers (liver, kidney, prostate, lung and germ cell) and found that top-ranked FFLs account for ~20% of transcriptome changes between normal and cancer. We have identified common FFL regulators across multiple cancer types, such as known FFLs consisting of MYC and miR-15/miR-17 families, and novel FFLs consisting of ARNT, CREB1 and their miRNA partners. The results and analysis web server are available at http://www.canevolve.org/dChip-GemiNi.
机译:我们在这里描述了一种新的方法,用于使用由转录因子(TFs),miRNA及其常见靶基因组成的前馈环(FFL)整合癌症中的基因和miRNA表达谱。 dChip-GemiNI(基于基因和基于miRNA网络的整合)方法通过其预测能力对计算预测的FFL进行统计学排名,以解释正常和癌症等两种生物学状况之间的差异基因和miRNA表达。 GemiNI不仅整合了基因和miRNA的表达数据,而且还整合了有关TF-靶基因和miRNA-mRNA相互作用的计算信息。文献验证表明,与现有方法相比,表达数据和FFL的集成建模可以更好地识别与癌症相关的TF和miRNA。我们已经利用GemiNI分析了六种实体癌(肝,肾,前列腺,肺和生殖细胞)的数据集,发现排名最高的FFL占正常和癌症之间转录组变化的约20%。我们已经确定了跨多种癌症类型的常见FFL调节剂,例如由MYC和miR-15 / miR-17家族组成的已知FFL,以及由ARNT,CREB1及其miRNA伴侣组成的新型FFL。结果和分析Web服务器可从http://www.canevolve.org/dChip-GemiNi获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号